A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Tela Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 148,900 shares of TELA stock, worth $415,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148,900
Previous 78,300 90.17%
Holding current value
$415,431
Previous $368,000 2.17%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.32 - $5.04 $163,792 - $355,824
70,600 Added 90.17%
148,900 $376,000
Q2 2024

Aug 09, 2024

BUY
$4.39 - $6.36 $343,737 - $497,988
78,300 New
78,300 $368,000
Q4 2023

Feb 13, 2024

SELL
$4.5 - $7.51 $107,550 - $179,489
-23,900 Reduced 70.09%
10,200 $68,000
Q3 2023

Nov 14, 2023

SELL
$7.85 - $10.68 $101,265 - $137,772
-12,900 Reduced 27.45%
34,100 $273,000
Q2 2023

Aug 11, 2023

SELL
$9.23 - $11.23 $209,521 - $254,921
-22,700 Reduced 32.57%
47,000 $476,000
Q1 2023

May 12, 2023

BUY
$9.41 - $12.03 $9,108 - $11,645
968 Added 1.41%
69,700 $742,000
Q4 2022

Feb 13, 2023

SELL
$6.5 - $11.5 $8,242 - $14,582
-1,268 Reduced 1.81%
68,732 $790,000
Q3 2022

Nov 14, 2022

BUY
$7.36 - $9.15 $427,616 - $531,615
58,100 Added 488.24%
70,000 $596,000
Q2 2022

Aug 12, 2022

BUY
$5.54 - $11.49 $65,926 - $136,731
11,900 New
11,900 $83,000
Q1 2022

May 13, 2022

SELL
$11.35 - $13.7 $119,413 - $144,137
-10,521 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$11.95 - $13.34 $211,264 - $235,837
-17,679 Reduced 62.69%
10,521 $135,000
Q3 2021

Nov 12, 2021

SELL
$12.2 - $15.93 $212,280 - $277,182
-17,400 Reduced 38.16%
28,200 $385,000
Q2 2021

Aug 13, 2021

BUY
$11.7 - $16.11 $194,220 - $267,426
16,600 Added 57.24%
45,600 $735,000
Q1 2021

May 13, 2021

BUY
$12.84 - $17.26 $372,360 - $500,540
29,000 New
29,000 $432,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $53.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.